SQUAT: neoadjuvant chemo-immuno-radiation and surgery in NSCLC

Lung Cancer | Surgery vs chemo-radiotherapy | Adjuvant ImmunotherapyПодробнее

Neoadjuvant Chemotherapy vs. Chemo/Radiation for Stage IIIA NSCLCПодробнее

Surgical perspective on neoadjuvant IO for resectable stage III NSCLCПодробнее

Improving outcomes in NSCLC with perioperative targeted therapiesПодробнее

8 in 8 Series: Neoadjuvant Biomarker Trials in Lung CancerПодробнее

Adherence & outcomes of neoadjuvant immunotherapy in resectable NSCLCПодробнее

I-O Therapy Versus Surgery or Chemotherapy in NSCLCПодробнее

Dr. Nasser Altorki: Neoadjuvant immunotherapy and radiation boosts response in NSCLCПодробнее

Neoadjuvant, Adjuvant, or Both: Individualized Perioperative Immunotherapy in Resectable NSCLCПодробнее

The Role of Surgery in NSCLC Following PACIFIC TrialПодробнее

Pre-Operative/Neoadjuvant Therapy: Rationale and IndicationsПодробнее

Neoadjuvant and adjuvant immunotherapy in non-small cell lung cancerПодробнее

Surgical outcomes from CheckMate 816: NIVO plus chemo vs chemo alone as neoadjuvant treatment fo...Подробнее

8 in 8 Series: Biomarker Testing and Neoadjuvant Immunotherapy for Resectable NSCLCПодробнее

Advances in Immunotherapy & Resectable Non-Small Cell Lung CancerПодробнее

Precision Oncology in Early-Stage Lung Cancer, With Adjuvant EGFR-Targeted Therapy Leading the WayПодробнее

Dr. Weksler on Neoadjuvant and Adjuvant Therapy in NSCLCПодробнее

Adjuvant-Neoadjuvant treatment | Lung Cancer | Latest Innovation | Immunotherapy | Targeted therapyПодробнее

Surgery, Radiotherapy, and Neoadjuvant Chemotherapy for Advanced STSПодробнее